The SENS Research Group (SRG) is a non-profit association that aims to support research of the unconscious sensory processing sensitivity (SPS).
Scientifically supported methods, such as the SENS-E-Screening method, are therefore being developed to conduct experimental and clinical studies. The SENS-E-Screening method was the first to prove the link between SPS and atopic diseases, e.g. neurodermatitis, bronchial asthma, hay fever and allergies (Liffler P., Peters E., Gieler U., 2019).
A second study also revealed the dependence of the most common mental disorders, such as anxiety disorders and unipolar depression, on increased SPS levels (Liffler P., Fölster-Holst R., Gieler U. u. Peters E., 2020). These revolutionary findings for the first time enable causal treatments which will lead to significant savings in medications. Large sample clinical trials will examine the effectiveness of the new preventive and therapeutic options.
The feeling of a unified consciousness, the feeling to decide and act self-determined, is obviously an illusion. Recent studies show that our thinking and actions are far more influenced by sensory processing sensitivity, meaning unconscious processes, than we thought.
Head of the psychoneuroimmunology laboratory, education and communication of the connections between stress in its various qualities and the neuroimmunological connections in chronic diseases such as neurodermatitis and skin cancer. Research into the effects and efficiency of psychosocial interventions.
Deputy Head and senior clinical senior physician at the Clinic for Psychosomatics and Psychotherapy (Head: Prof. Dr. Johannes Kruse).
Expert in atopic eczema (neurodermatitis), allergies and pediatric dermatology. Chairwoman of the Medical Association of German Allergologists in Northern Germany and the Working Group on Pediatric Dermatology in the German Dermatological Society. Prof. Fölster-Holst has been President of the European Society for Pediatric Dermatology (ESPD) since 2016.
Until 2019 head physician at the children's clinic Bellevue for atopic diseases. Discovery of the dependence of atopic diseases on sensory processing sensitivity in 2016.
The randomized and controlled study (RCT) is proven to be the best study design in medical research. For example if you try to make a clear statement about the effectiveness of a therapeutic procedure. These studies are complex and expensive. Not few promising medical trials have failed the financial hurdle. Even traditional and tried and tested complementary medical procedures were refused recognition due to the fact.
We believe our research project is worth its pursuit. If you would like to support it, you can do so with a membership in the support association (annual fee 50,- Euros) or with a tax-deductible donation. At the same time, we are applying for funding from all institutions and associations involved in the healthcare sector.
We also need as many volunteers as possible for our studies, which is why we are very happy about an anonymous participation in the SENS test. If you are convinced by our work, please share this site with your friends and contacts on social media. All of this will help our research and hence hopefully many people in the future.
Thanks for your interest
SENS Research Group
c/o Dr. Peter Liffler
23769 Fehmarn OT Petersdorf
Tel.: +49 (0) 160 90 91 89 92